This page contains links to guidance and information documents for Healthcare Professionals.

 

Below are two important position statements issued by the DAFNE Executive Board. Their purpose is to clarify our current position on background insulin, and on fasting hyperglycaemia. Both statements have a firm evidence base, and the background insulin position is also informed by audit of insulin and outcomes from the DAFNE research database.  Click the relevant links below to view the documents.

 

Interpretation and management of fasting hyperglycaemia

Restoring hypo awareness in Type 1 diabetes

Insulin Statement


Last Updated: 04/12/2015